IL124768A0 - Novel pyridine compounds processes for their preparation and their use as pharmaceutical agents - Google Patents

Novel pyridine compounds processes for their preparation and their use as pharmaceutical agents

Info

Publication number
IL124768A0
IL124768A0 IL12476896A IL12476896A IL124768A0 IL 124768 A0 IL124768 A0 IL 124768A0 IL 12476896 A IL12476896 A IL 12476896A IL 12476896 A IL12476896 A IL 12476896A IL 124768 A0 IL124768 A0 IL 124768A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical agents
pyridine compounds
novel pyridine
compounds processes
Prior art date
Application number
IL12476896A
Other languages
English (en)
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9524920.7A external-priority patent/GB9524920D0/en
Priority claimed from GBGB9609403.2A external-priority patent/GB9609403D0/en
Priority claimed from GBGB9622412.6A external-priority patent/GB9622412D0/en
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of IL124768A0 publication Critical patent/IL124768A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IL12476896A 1995-12-06 1996-12-04 Novel pyridine compounds processes for their preparation and their use as pharmaceutical agents IL124768A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9524920.7A GB9524920D0 (en) 1995-12-06 1995-12-06 Compounds
GBGB9609403.2A GB9609403D0 (en) 1996-05-04 1996-05-04 Compounds
GBGB9622412.6A GB9622412D0 (en) 1996-10-22 1996-10-22 Compounds
PCT/SE1996/001595 WO1997020815A1 (en) 1995-12-06 1996-12-04 Compounds

Publications (1)

Publication Number Publication Date
IL124768A0 true IL124768A0 (en) 1999-11-30

Family

ID=27268017

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12476896A IL124768A0 (en) 1995-12-06 1996-12-04 Novel pyridine compounds processes for their preparation and their use as pharmaceutical agents

Country Status (20)

Country Link
US (1) US5977105A (no)
EP (1) EP0865431A2 (no)
JP (1) JP2000501700A (no)
KR (1) KR19990071968A (no)
CN (1) CN1208403A (no)
AR (1) AR004893A1 (no)
AU (1) AU711772B2 (no)
BR (1) BR9611555A (no)
CZ (1) CZ172498A3 (no)
EE (1) EE9800172A (no)
HU (1) HUP9900143A3 (no)
IL (1) IL124768A0 (no)
IS (1) IS4739A (no)
MX (1) MX9804295A (no)
NO (1) NO982566L (no)
NZ (1) NZ323521A (no)
SA (1) SA97170633A (no)
SK (1) SK73998A3 (no)
TR (1) TR199801000T2 (no)
WO (1) WO1997020815A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037070A1 (fr) * 1997-02-21 1998-08-27 Takeda Chemical Industries, Ltd. Composes a anneaux condenses, leur procede de production et leur utilisation
AU6753298A (en) * 1997-03-25 1998-10-20 Astra Pharmaceuticals Limited Novel pyridine derivatives and pharmaceutical compositions containing them
CA2284200A1 (en) * 1997-03-25 1998-10-01 Astra Pharmaceuticals Ltd. Novel pyridine derivatives and pharmaceutical compositions containing them
EP0984961B1 (en) * 1997-04-01 2001-06-20 AstraZeneca AB Novel pyridine derivatives and pharmaceutical compositions containing them
SE9803107D0 (sv) * 1998-09-14 1998-09-14 Astra Pharma Prod Novel Compunds
SE9803277D0 (sv) * 1998-09-25 1998-09-25 Astra Pharma Prod Novel compounds
SE9803279D0 (sv) * 1998-09-25 1998-09-25 Astra Pharma Prod Novel compounds
SE9803280D0 (sv) * 1998-09-25 1998-09-25 Astra Pharma Prod Novel compounds
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6307049B1 (en) * 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
EP1140844A1 (en) * 1999-01-08 2001-10-10 Vertex Pharmaceuticals Incorporated Process for the formation of intermediates useful for the preparation of pharmaceuticals
SE9901079D0 (sv) * 1999-03-23 1999-03-23 Astra Ab Novel compounds
CA2314458A1 (en) * 1999-08-02 2001-02-02 Kazumi Okuro Process for production of 3-(3-pyridyl)-1-propanol derivatives
US6376524B1 (en) 2000-06-21 2002-04-23 Sunesis Pharmaceuticals, Inc. Triphenyl compounds as interleukin-4 antagonists
GB0321538D0 (en) * 2003-09-13 2003-10-15 Glaxo Group Ltd Therapeutically useful compounds
MX2009004904A (es) * 2006-11-09 2009-05-19 Bausch & Lomb Sintesis de estereoisomeros seleccionados de ciertos alcoholes sustituidos.
WO2008154484A1 (en) 2007-06-08 2008-12-18 Mannkind Corporation Ire-1a inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA877650B (en) * 1986-10-14 1988-12-28 Searle & Co Alpha-(phenylalkyl)pyridinealkanol derivatives
AU7975887A (en) * 1986-10-16 1988-04-21 G.D. Searle & Co. Alpha-((phenylmethoxy)methyl)pyridine alkanols
US5248685A (en) * 1989-04-07 1993-09-28 Pfizer Inc. Substituted 1-[3-(heteroarylmethoxy)phenyl]alkanols and related compounds in the treatment of asthma

Also Published As

Publication number Publication date
CZ172498A3 (cs) 1998-12-16
SA97170633A (ar) 2005-12-03
MX9804295A (es) 1998-09-30
HUP9900143A2 (hu) 1999-05-28
TR199801000T2 (xx) 1998-08-21
JP2000501700A (ja) 2000-02-15
BR9611555A (pt) 1999-03-02
HUP9900143A3 (en) 2000-04-28
SK73998A3 (en) 1999-02-11
AU1048097A (en) 1997-06-27
EP0865431A2 (en) 1998-09-23
WO1997020815A1 (en) 1997-06-12
NO982566L (no) 1998-07-24
NO982566D0 (no) 1998-06-04
EE9800172A (et) 1998-12-15
IS4739A (is) 1998-05-12
KR19990071968A (ko) 1999-09-27
CN1208403A (zh) 1999-02-17
AR004893A1 (es) 1999-03-10
NZ323521A (en) 1999-10-28
AU711772B2 (en) 1999-10-21
US5977105A (en) 1999-11-02

Similar Documents

Publication Publication Date Title
GR3031304T3 (en) 6-Dimethylaminomethyl-1-phenyl-cyclo-hexane compounds as pharmaceutical agents
GR3032486T3 (en) 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol derivatives as pharmaceutical agents
ZA9810490B (en) 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
HU9601698D0 (en) Pharmaceutical composition
IL123986A0 (en) Antithombotic agents process for their preparation and pharmaceutical compositions comprising them
HUP9800138A3 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives, process for producing them, pharmaceutical compositions containing the same and their use
IL124768A0 (en) Novel pyridine compounds processes for their preparation and their use as pharmaceutical agents
IL117620A0 (en) Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
HUP9901485A3 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
GB9519667D0 (en) Pharmaceutical composition
ZA962214B (en) Pharmaceutical composition
ZA963590B (en) Pharmaceutical composition
HUP9802741A3 (en) Pharmaceutical composition containing tiagabine or its salt and the process for its preparation
HUP9601680A3 (en) Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds
GB9525194D0 (en) Pharmaceutical composition
ZA961051B (en) Pharmaceutical composition
HUP9801068A3 (en) 1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them
ZA963350B (en) Cycloheaxane compounds process for their preparation and pharmaceutical compositions containing them
ZA96526B (en) Novel pharmaceutical formulation
ZA964193B (en) Pharmaceutical composition
GB9518553D0 (en) New urea derivatives processes for the preparation thereof and pharmaceutical composition comprising the same
HUP9602324A3 (en) Piperidinyl-methyl-oxazolidinon derivatives, pharmaceutical compositions containing the same, process for the preparation of the compounds and use of them
HUP9602822A2 (en) Pharmaceutical composition
ZA963591B (en) Pharmaceutical composition
ZA95736B (en) Pharmaceutical composition